Descripción
Specifications
Source |
Biotinylated Human BAFF/TNFSF13B/CD257 Trimer Protein is expressed from HEK293 with His tag and Avi tag at the N-terminal. It contains Thr141-Leu285.[Accession | Q9Y275-1] |
Molecular Weight |
The protein has a predicted MW of 54.2 kDa. Due to glycosylation, the protein migrates to 55-68 kDa based on Tris-Bis PAGE result. |
Endotoxin |
Less than 1EU per μg by the LAL method. |
Purity |
> 95% as determined by Tris-Bis PAGE |
Activity |
ELISA Data: Immobilized Human BAFFR, hFc Tag at 5μg/ml (100μl/Well) on the plate. Dose response curve for Biotinylated Human BAFF (Trimer) , His Tag with the EC50 of 6.9ng/ml determined by ELISA. |
Formulation |
Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 5% trehalose is added as protectant before lyophilization. |
Reconstitution |
Centrifuge tubes before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. |
Storage
The product should be stored at -25~-15℃ for 1 year from the date of receipt.
2-7 days, 2 ~8 °C under sterile conditions after reconstitution.
3 months, -25~-15℃ under sterile conditions after reconstitution.
Recommend to aliquot the protein into smaller quantities when first used and avoid repeated freeze-thaw cycles.
Note
1.Please operate with lab coats and disposable gloves for your safety.
2.This product is for research use only.
Pago y seguridad
Su información de pago se procesa de forma segura. No almacenamos detalles de la tarjeta de crédito ni tenemos acceso a la información de su tarjeta de crédito.
Consulta
También te puede gustar
Preguntas frecuentes
El producto es solo para fines de investigación y no está destinado a uso terapéutico o diagnóstico en humanos o animales. Los productos y el contenido están protegidos por patentes, marcas comerciales y derechos de autor propiedad de Yeasen Biotechnology. Los símbolos de marca comercial indican el país de origen, no necesariamente el registro en todas las regiones.
Algunas aplicaciones pueden requerir derechos de propiedad intelectual adicionales de terceros.
Yeasen se dedica a la ciencia ética y cree que nuestra investigación debe abordar cuestiones críticas al tiempo que garantiza la seguridad y los estándares éticos.